Dakota-Scott Workforce Development Board recognized Prime Therapeutics as a 2021 Employer of Excellence

Prime Therapeutics (Prime) is one of the ten organizations recognized as a 2021 Employer of Excellence by the Dakota-Scott Workforce Development Board. The program honors employers in Dakota and Scott counties for exemplary practices to attract and retain employees. Prime made the list in 2021 for the third time, in part due to its employee engagement initiatives including the Welcome Ambassadors program, which replaces a single onboarding event. Prime also stood out for its Diversity & Inclusion Council and employee resource groups (ERGs) which help champion diversity and inclusion awareness, initiatives, outreach and events.

Senior Vice President and Chief Human Resources Officer Erin Feigal today accepted the award on behalf of Prime during a virtual event. “Of course, we’re focused on making the right hires, but our ‘radical welcomeness’ approach introduces new Prime joiners to all aspects of our culture, giving them the opportunity to network outside of their work,” said Feigal. This long-term, holistic experience is designed to keep new hires engaged throughout their Prime journey.”

Participants completed a 41-question survey that allowed their employment practices to be analyzed by a consulting firm. Employers were ranked in 37 categories including rate of employee growth, benefits offered and percentage of employees who attended training in 2020.

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Stories

May 2, 2024

Prime discusses leading medically integrated dispensing model at Asembia

Connecting specialty pharmacies and providers to unlock optimal care and value

Stories

April 30, 2024

RECAP: Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2024

Stories, perspectives and news coverage of Prime Therapeutics/Magellan Rx from AMCP 2024

Stories

April 24, 2024

New study conducted by Prime Therapeutics researchers offers insights into ways to increase equity in health care

Research published in the Journal of Managed Care & Specialty Pharmacy uses population data to fill gaps in social determinants of health data, providing a more complete understanding of a patient’s global health circumstances

View all news